GRAL Company Profile and Key Details

Short-term trend indicators are mixed aligned (SMA20 -33.79%, SMA50 -37.7%, SMA200 -10.47%). The stock’s 14-day RSI is 34.26 (weak momentum), while the ATR of 10.03 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -51.11% below its high and over 184.25% above its low. Average 10-day trading volume of 1.06 million shares is below the 3-month average of 1.33 million, indicating normal recent market interest.

GRAIL, Inc. has 36.05 million shares outstanding. The public float is 24.18 million shares, elevated short interest at 15.40% of float. This equals 4.81 million shares. The short ratio is 4.38 days. Institutional investors hold 85.03% of the float. Insiders own 13.81%. ILLUMINA, INC. holds 3.50 million shares, DING CHUN R has 3.31 million shares and RAGUSA ROBERT P has 518.58 thousand shares. Over the past six months, insider transactions show net selling. They sold 1.30 million shares across 17 transactions.

GRAIL, Inc. generated EPS of -$11.18 over the past year. Five-year average earnings growth is -41.05%. Wall Street analysts project EPS growth of 1.77% annually over the next five years. Analyst sentiment is bullish. Analyst rating data shows there are 2 Strong Buy ratings, 7 Buy ratings, 4 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $130.00 to $54.00. The high target offers 157.48% upside. The low target suggests 6.95% downside. The mean target is $94.85. This offers 87.86% upside. GRAIL, Inc. earnings surprise history is a mixed track record. The quarter that ended November 12, 2025, missed forecasts by -27.56%. The prior quarter beat by 1.27%. Over the last six quarters, Apple has recorded several small beats. These include -38.72% in November 12, 2024.

GRAIL, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$70.29. This means the shares are trading below this model’s fair value.

GRAIL, Inc. (NASDAQ:GRAL) closed at $49.84 USD, gaining $0.05 (0.10%) from the previous close of $49.79. The stock is currently mid-range between its 52-week high and low $25.56 and $118.84. With a market capitalization of about $2.04 billion, GRAIL, Inc. is classified as a mid-cap and shows higher-than-market volatility (beta ~4.64). Key stats such as the average daily volume over the past year has been around 1.34 million shares, volume is running light vs its 52-week average. Headquartered in Menlo Park, CA, GRAIL, Inc. operates in the Healthcare sector and the Medical - Diagnostics & Research industry. Led by CEO Robert Ragusa, the company employs approximately 1,000 people and listed since June 12, 2024. GRAIL, Inc., a biotechnology company, focuses on developing technologies for early cancer detection.

GRAIL, Inc. trades at a P/E ratio of -4.97, slightly below the S&P 500 average, with a price-to-sales ratio of 13.9 and a price-to-book ratio of 0.79 suggesting the stock is closer to book value. The P/FCF stands at -6.84, also below market averages.

GRAIL, Inc. (NASDAQ:GRAL) shares are up 18.37% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows GRAIL, Inc. trading at a premium to the broader market with a P/E of -4.97. Analyst sentiment is mixed, with the majority of ratings in Neutral territory and a mean price target of $84.60, suggesting 67.56% upside. Our AI forecast model points to short-term weakness (-6.32% over two weeks), a medium-term rise (55.61% over three months), and a longer-term gain (80.06% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that GRAIL, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -6.32%, with price expected at $47.30 by April 28, 2026, within a range of $37.27 to $57.57 3-Month Outlook: Projected rise of 55.61%, reaching $78.57 by July 13, 2026, with a range of $74.98 to $82.40. 1-Year Outlook: Projected gain of 80.06%, with price at $90.91 by April 14, 2027, within a range of $84.78 to $97.97.